跳至主要内容
临床试验/CTRI/2018/05/013917
CTRI/2018/05/013917进行中(未招募)2 期

A Randomized prospective study comparing Neoadjuvant treatment Response in Rectal Cancer, Short Course Radiotherapy followed by Chemotherapy versus Conventional Chemo-radiation: A North East India Based Tertiary Care Hospital Experience

Shashank Bansal0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
2 期
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • Age >= 18 years and < 70 years
  • ECOG performance score <= 1
  • Written informed consent
  • Biopsy proven rectal adenocarcinoma
  • Metastatic lateral lymphnodes (LN+)
  • Involved mesorectal fascia (MRF+)
  • Locally advanced tumour fulfilling at least one of the following criteria on pelvic MRI:
  • cT2 ,cT3,cT4a
  • Creatinine levels indicating renal clearance >= 50 ml/min
  • Bilirubin < 35 μmol/L

排除标准

  • Tumour involving lumbosacral nerve roots
  • Distant metastasis (M1)
  • Recurrent rectal cancer
  • FAP or HNPCC, Active Chrons disease
  • Contraindications to MRI (e.g. pacemaker)
  • Myocardial infarction within past 12 months or clinically significant cardiac disease
  • Inability to give informed consent
  • Concomitant malignancies

研究者

发起方
Shashank Bansal

相似试验